Latest News - Liechtenstein

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Thursday, January 18, 2018

2:44:00 PM CET

Subscribe
RSS

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
lb
lo
lt
lv
mk
ml
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Country info

LI

Liechtenstein (LI)

All news about Liechtenstein

All news sources from Liechtenstein

LI

AlertLevel (24h)

Alert level graph

 Previous 14 days average

Alert level:
 high   medium   low

Quotes... Extracted quotes

Marco Abele said: "We have already received a significant number of requests to participate in our Token Sale using Swiss francs. These inquiries come from sources either eager to take their first step into investing in crypto tokens, or those that aim to add to their token portfolio without needing to draw on their increasingly valuable existing crypto token holdings. We are delighted to be able to provide this facility," External link

finanznachrichten-en Wednesday, January 17, 2018 11:04:00 PM CET

Marco Abele said: "The TEND organization feel privileged to have been chosen by the ETH Zurich Chair of Entrepreneurship, who selected us based on our outstanding team and renowned advisors, the already developed alpha version of the product, and our aim of designing new standards for token sales," External link

finanznachrichten-en Wednesday, January 17, 2018 11:04:00 PM CET

Donald Trump said: “We cannot let a murderous regime continue these destabilizing activities,” External link

un-org Friday, December 29, 2017 6:32:00 PM CET

Antonio Guterres said: “The only world that is safe from the use of nuclear weapons is a world that is completely free of nuclear weapons,” External link

un-org Friday, December 29, 2017 6:32:00 PM CET

Nikki R Haley said: “America will put its embassy in Jerusalem,” External link

un-org Friday, December 29, 2017 6:32:00 PM CET

Eric Sidgwick said: “Việt Nam has been experiencing remarkable growth over the last few years. However, the majority of economic gains have accrued in the urban areas, with rural areas, including provinces in the northeast, lagging behind,” External link

vietnamnet-en Thursday, December 21, 2017 6:02:00 AM CET

Mitsuo Satoh sagte: "Unsere Wissenschaftler bei Kyowa Hakko Kirin waren die ersten, die FGF23 entdeckt, erfolgreich geklont und die Rolle des Proteins bei der Behandlung von Krankheiten identifiziert haben, bei denen in übermäßigem Maße Phosphat abgebaut wird. Dies gab den Anlass zu einem intensiven Forschungsprogramm und der klinischen Entwicklungszusammenarbeit mit Ultragenyx, bei der Burosumab entwickelt wurde, ein Antikörper gegen FGF23" External link

ots Friday, December 15, 2017 3:42:00 PM CET

Mitsuo Satoh dijo: "Nuestros científicos en Kyowa Hakko Kirin fueron los primeros en descubrir y tener éxito en la clonación FGF23 e identificar el papel de la proteína en el tratamiento de enfermedades de pérdida de fosfato. Esto llevó a un programa de investigación sólido y colaboración para el desarrollo clínico con Ultragenyx para desarrollar burosumab, un anticuerpo para FGF23," External link

prnewswire Friday, December 15, 2017 2:50:00 PM CET

Belen Garijo afirma: “La esclerosis múltiple (EM) es uno de los trastornos neurológicos más comunes en el mundo. Con la aprobación de Cladribina tabletas en la Unión Europea podremos ofrecer a los pacientes y a los profesionales médicos un tratamiento innovador con un régimen de dosificación simplificado que representa un nuevo enfoque en el manejo de la EM recurrente remitente (EMRR)” External link

laprensagrafica Sunday, December 10, 2017 4:17:00 AM CET

Themes

Country themes

Daily number of articles in this category

Trend data not available for this selection.